Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (ATEZOTRIBE): a multicentre, open-label, phase 2, randomised controlled trial
Year: 2022
Type: dissertation
Study designs: Randomized Controlled Trial, Clinical Trial
Author: ZUCCHELLI, GEMMA
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7015876239
